Activated cathepsin L is associated with the switch from autophagy to apoptotic death of SH-SY5Y cells exposed to 6-hydroxydopamine

Biochemical and Biophysical Research Communications
Ling-yun LiZhong-qin Liang

Abstract

Autophagy and apoptosis are common responses to pathological damage in the process of Parkinson's disease (PD), and lysosome dysfunction may contribute to the etiology of PD's neurodegenerative process. In this study, we demonstrated that the neurotoxin 6-hydroxydopamine (6-OHDA) increased autophagy in SH-SY5Y cells, as determined by detection of the lysosome marker lysosomal-associated membrane protein1, the autophagy protein light chain 3 (LC3)-II and the autophagy substrate P62 protein. Meanwhile, autophagy repression with 3-methyladenine accelerated the activation of caspase-3 and PARP and aggravated the cell apoptotic death induced by 6-OHDA. Furthermore, we found that 6-OHDA treatment resulted in a transient increase in the intracellular and nuclear expression of cathepsin L (CTSL). The CTSL inhibitor, Z-FY-CHO, could promote autophagy, decrease accumulation of P62, and block activation of caspase-3 and PARP. Taken together, these results suggest that activation of autophagy may primarily be a protective process in SH-SY5Y cell death induced by 6-OHDA, and the nuclear translocation of CTSL could enhance the cell apoptotic cascade via disturbing autophagy-apoptotic systems in SH-SY5Y cells. Our findings highlight the poten...Continue Reading

References

Nov 14, 2000·The Journal of Biological Chemistry·V StokaG S Salvesen
Jun 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ute FelborBjorn R Olsen
Apr 1, 2003·Annals of Neurology·William G TattonNadine Tatton
Jul 18, 2003·Journal of Neuroscience Research·Cristina Gómez-SantosSantiago Ambrosio
Dec 3, 2003·Cell Death and Differentiation·M JäätteläG Kroemer
May 12, 2005·Parkinsonism & Related Disorders·Serge Przedborski
Apr 26, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ivonne PetermannThomas Reinheckel
Sep 16, 2006·Biological Chemistry·Brigitte GouletAlain Nepveu
Jun 21, 2007·The Journal of Biological Chemistry·Serhiy PankivTerje Johansen
Sep 4, 2007·Biochimica Et Biophysica Acta·Sonja StahlUte Felbor
Jan 12, 2008·Brain : a Journal of Neurology·Tianhong PanJoseph Jankovic
May 5, 2009·Neurotoxicology·Pol Giménez-XavierSantiago Ambrosio
Aug 6, 2009·Human Molecular Genetics·Yipeng WangEckhard Mandelkow
Dec 8, 2010·Neuroscience Letters·Lingyun LiZhongqin Liang
Apr 3, 2012·Experimental Cell Research·Maruša Hafner ČesenBoris Turk
Aug 21, 2013·Neuropharmacology·Anja Hafner PišlarJanko Kos
Nov 12, 2013·Progress in Neurobiology·Saeid GhavamiMarek J Łos
Nov 23, 2013·Parkinsonism & Related Disorders·Junghyun LimYoung J Oh
Apr 7, 2015·Seminars in Cell & Developmental Biology·Marta Martinez-Vicente
Aug 25, 2015·Pharmacology & Therapeutics·Dhivya R Sudhan, Dietmar W Siemann

❮ Previous
Next ❯

Citations

Aug 16, 2016·International Journal of Molecular Sciences·Imène AchourMaria-Grazia Martinoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis